Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$13.35−0.37 (-2.70%)
Close on Nov 12, 2026Market cap $2.01BP/E –Yield 3.84%
Chemours total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Chemours's total debt was $3.83B at Sep 30, 2026. For fiscal 2025 it was $4.14B, up 0.7% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is $4.16B in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14B | +0.7% |
| FY2024 | Dec 31, 2024 | $4.11B | +1.8% |
| FY2023 | Dec 31, 2023 | $4.04B | +11.2% |
| FY2022 | Dec 31, 2022 | $3.63B | -3.1% |
| FY2021 | Dec 31, 2021 | $3.75B | -6.9% |
| FY2020 | Dec 31, 2020 | $4.03B | -3.2% |
| FY2019 | Dec 31, 2019 | $4.16B | +4.7% |
| FY2018 | Dec 31, 2018 | $3.97B | -3.4% |
| FY2017 | Dec 31, 2017 | $4.11B | +16.0% |
| FY2016 | Dec 31, 2016 | $3.54B | -10.4% |
| FY2015 | Dec 31, 2015 | $3.95B | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.83B | -7.8% |
| Q2 FY2026 | Jun 30, 2026 | $3.87B | -6.6% |
| Q1 FY2026 | Mar 31, 2026 | $4.14B | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | $4.14B | +0.7% |
| Q3 FY2025 | Sep 30, 2025 | $4.16B | +2.8% |
| Q2 FY2025 | Jun 30, 2025 | $4.15B | +3.9% |
| Q1 FY2025 | Mar 31, 2025 | $4.11B | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $4.11B | +1.8% |
| Q3 FY2024 | Sep 30, 2024 | $4.04B | +1.5% |
| Q2 FY2024 | Jun 30, 2024 | $3.99B | +9.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.01B | +10.0% |
| Q4 FY2023 | Dec 31, 2023 | $4.04B | +11.2% |
| Q3 FY2023 | Sep 30, 2023 | $3.98B | +12.7% |
| Q2 FY2023 | Jun 30, 2023 | $3.65B | -0.9% |
| Q1 FY2023 | Mar 31, 2023 | $3.65B | -1.8% |
| Q4 FY2022 | Dec 31, 2022 | $3.63B | -3.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.53B | -8.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.68B | -7.7% |
| Q1 FY2022 | Mar 31, 2022 | $3.72B | -6.9% |
| Q4 FY2021 | Dec 31, 2021 | $3.75B | -6.9% |
| Q3 FY2021 | Sep 30, 2021 | $3.85B | -5.9% |
| Q2 FY2021 | Jun 30, 2021 | $3.99B | -8.2% |
| Q1 FY2021 | Mar 31, 2021 | $3.99B | -1.0% |
| Q4 FY2020 | Dec 31, 2020 | $4.03B | -3.2% |
| Q3 FY2020 | Sep 30, 2020 | $4.10B | -1.5% |
| Q2 FY2020 | Jun 30, 2020 | $4.35B | +3.3% |
| Q1 FY2020 | Mar 31, 2020 | $4.03B | +1.4% |
| Q4 FY2019 | Dec 31, 2019 | $4.16B | +4.7% |
| Q3 FY2019 | Sep 30, 2019 | $4.16B | +3.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.21B | +5.9% |
| Q1 FY2019 | Mar 31, 2019 | $3.98B | -4.3% |
| Q4 FY2018 | Dec 31, 2018 | $3.97B | -3.4% |
| Q3 FY2018 | Sep 30, 2018 | $4.00B | -2.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.97B | -2.4% |
| Q1 FY2018 | Mar 31, 2018 | $4.16B | +17.0% |
| Q4 FY2017 | Dec 31, 2017 | $4.11B | +16.0% |
| Q3 FY2017 | Sep 30, 2017 | $4.10B | – |
| Q2 FY2017 | Jun 30, 2017 | $4.07B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.55B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.54B | – |
See a number that looks wrong?